Community Pharmacists' Knowledge and Attitudes Towards Pediatric Pain Management in Nigeria.

PURPOSE: Community pharmacists (CPs) frequently attend to pediatric patients with pain but limited data exist regarding their knowledge of and attitude to effective management of pediatric pain in Nigeria. Thus, this study aimed to evaluate the knowledge of and attitude to pediatric pain management among CPs in Nigeria. PATIENTS AND METHODS: A validated and pilot-tested questionnaire, the Community Pharmacists Survey on Pediatric Pain, was administered to 517 eligible participants at the 38th Annual National Conference of the Association of Community Pharmacists of Nigeria. Independent samples t-test and one-way analysis of variance were used for inferential statistical analyses.
RESULTS: CPs with additional higher academic qualifications and clinically related additional academic degrees had significantly higher mean knowledge scores relative to first degree only holder counterpart (t= 4.33, p< 0.05, Eta2=0.05) and those without clinically related second degrees (t= 6.34, p< 0.05, Eta2=0.27). Pain knowledge among the study cohort also varied significantly by age group, years of practicing community pharmacy, ownership structure of premises, geographical location of practice and previous exposure to pain management training (F(4370)=2.858, p=0.025, Eta2=0.03; F(3371)=3.985, p=0.008, Eta2=0.03; F(2372)=3.643, p=0.027, Eta2=0.02; F(5369)=4.497, p=0.01, Eta2=0.06; F(2372)=3.587, p=0.029, Eta2=0.02), respectively.
CONCLUSION: Community pharmacists' knowledge of and attitude to pediatric pain management in Nigeria appeared sub-optimal, and requires regular targeted educational intervention to fill the identified gaps, improve service delivery and patient outcomes.

Plain Language Summary

Pain is a common sign of many ailments and diseases and community pharmacists are often the first port of call for the management of such diseases. Consequently, community pharmacists frequently attend to children with pain in their premises. However, limited data exists regarding the knowledge of such community pharmacists. Therefore, we conducted a survey among 517 community pharmacists during the 38th Annual National Conference of the Association of Community Pharmacists of Nigeria in 2019 to assess their knowledge of pediatric pain management.

Community pharmacists’ knowledge and attitude towards managing children with pain was found to be associated with having additional and clinically related higher academic degrees. Similarly, this association was also found for those who have had a previous pain management training, commenced practice within the last decade and are employees.

We concluded that community pharmacists’ knowledge and attitude towards managing children with pain in Nigeria is sub-optimal, and recommended tailored educational interventions such as pharmacy education curriculum modification where more time be allotted to pain management right from the undergraduate level and during the Mandatory Continuous Professional Development Program conducted by Pharmacists Council of Nigeria. We also recommend regular training and re-training of healthcare professionals across the country by relevant stakeholders such as Federal Ministry of Health.

Lastly, this survey revealed sub-optimal pediatric pain knowledge among the surveyed community pharmacists and this can impact how well children with pain are being managed. Knowing that undertreated pain in childhood has future adverse consequences underscores the importance of this survey finding.

Introduction

Pain is a subjective and non-discriminating phenomenon that can be defined as an unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage.1 Pain has also been recognized as a complex multidimensional experience involving the interaction of biological, psychological and social factors of the sufferer.2 Children with acute, chronic and neuropathic pain frequently present to healthcare settings including community pharmacies with the prevalence of those with chronic pain estimated to be between 20% and 35% worldwide.3–5 The economic burden of pediatric pain has not been adequately described in Nigeria. However, in resource-rich settings such as the United Kingdom, the cost of treating chronic pain in adolescents is estimated at £ 3.8 billion annually,6 and $ 19.5 billion per annum in the United States.7

Pain is the commonest reason for seeking the services of community pharmacists (CPs), making them an important component of the pain care continuum.8–10 Despite this high prevalence, pediatric pain continues to be under-diagnosed, and undertreated,11–15 and poor knowledge of healthcare providers (HCPs) about comprehensive pain management is one of the reasons identified.9,10,16–23 In order to address the “treatment gap” or “evidence-practice gap”,24,25 the Federal Ministry of Health (FMOH), Nigeria in collaboration with the American Cancer Society launched a program, Pain-Free Hospital Initiative (PFHI) in 2015 and trained over 11,000 HCPs including doctors, pharmacists, nurses and physiotherapists across 14 federal tertiary hospitals over a one-year period in order to integrate effective pain treatment into hospital-based service.26 However, this laudable initiative excluded community pharmacists. The Ministry went further in 2018 to launch the Guidelines for pain management in Nigeria, which considers pain management approach as interdisciplinary, patient-focused and recognizes the crucial role of pharmacists as pain care providers.26

Analgesics are the cornerstone of pain pharmacotherapy with over-the-counter (OTC) analgesics representing the largest market of OTC drug sales worldwide.27 However, studies have shown that pain management in pediatric patients is inadequate and associated with negative short-term consequences including prolonging hospitalization, poor quality of life and carrying significant cost to society,28,29 and long-term consequences such as poorer cognition and motor function, increased risk of developing chronic pain in adulthood and future avoidance of healthcare.30–35 Therefore, regular audit of pediatric pain management including assessment of the adequacy of the knowledge of the HCPs is warranted and could lead to the identification gaps that require intervention for improvement.

Moreover, previous studies on pain management involving pharmacists are few, mostly hospital-based and focused on adults with pain.19,21,36,37 Fewer studies still have involved community pharmacists but none has focused on pediatric pain.9,38,39 Hence, findings from the current study could provide new perspective that could add significantly to existing global knowledge in the research area. In addition, community pharmacists are Frontline healthcare professionals that are easily accessible especially at the primary care level and could contribute significantly to the effective management of pediatric pain in Nigeria. Thus, this study was undertaken to evaluate CPs’ knowledge of and attitude to pediatric pain management in Nigeria.

Materials and Methods

Design and Setting

This was a cross-sectional, descriptive survey involving a purposive sampling of 517 CPs. The sampling frame included all the community pharmacists (623) who attended the 38th Annual National Conference of the Association of Community Pharmacists of Nigeria (ACPN) that took place in Kano state, Nigeria between June 30, 2019 and July 6, 2019. The conference was the largest gathering of CPs in Nigeria and had attendees from the six geopolitical zones in Nigeria. Although 517 CPs agreed to participate in the study, however, only the data of 375 CPs were evaluated as per the study protocol.

Questionnaire Development and Validation

The questionnaire, community pharmacists survey on pediatric pain (CPSPP), comprised 40 items with three components-demographic characteristics, knowledge and practice was developed after a thorough review of relevant literature.20,23,40–46 The knowledge and attitude components were divided into four domains: multidimensional nature of pain, pain assessment and measurement, management of pain and clinical conditions; based on the IASP curriculum. These four domains of have been validated by Fishman et al.47

The psychometric evaluation of the knowledge component of CPSPP (which had 35 initial items identified after literature review) consisted of two phases. The first phase involved face and content validity assessment of the knowledge components of the questionnaire by a 7-member panel with expertise in pediatric pain management. The panel comprised of consultant anesthetist, clinical pharmacologists and pediatrician. It also included pharmacists who practice in the community, hospital and academia; and a registered senior nurse. The copy sent to the experts had a 5-point scale (varying from 1-not relevant to 5-very relevant) against each of the 35 items and space was also provided for comments such as reasons for the respective scores and suggestions for each item. The first phase resulted in the reduction of the knowledge component of the questionnaire items to 24 items with several modifications including rephrasing and reordering. For the second phase, which also served as pilot testing of CPSPP; the 24 knowledge and attitude items were administered to 23 CPs and this process was repeated after two weeks using the same version of CPSPP and group of 23 CPs. The result of reliability analysis via test-retest and the Cronbach’s alpha were 0.738 and 0.715, respectively.

The final version of the 42-item CPSPP had 9 items for demographics, 24 and 9 items, respectively, for knowledge and attitude, and practice of pediatric pain management. The demographics include questions relating to age, gender, highest qualification including degrees earned, years of qualification, years of practice as a community pharmacist, previous area of practice (and if yes, where), ownership and geopolitical zone location of the premises. The degrees include first degree such as Bachelor of Pharmacy, while second or third degree were sub-divided into clinically related and non-clinically related degrees. Clinically related degrees include Doctor of Pharmacy (Pharm D), Fellowship of West African Postgraduate College of Pharmacists, Masters in Clinical Pharmacy, Pharmacology, Pharmacoeconomics, Pharmaceutical Microbiology, Pharmaceutics, and Public Health; and PhD in Pharmacology. Non-clinically related degrees include Masters in Business Administration and Gender Studies, Postgraduate Diploma in Education and Bachelor of Law.

The knowledge and attitude items covered 4 pain domains: multidimensional nature of pain, pain assessment and measurement, management of pain, clinical conditions/pain syndromes. The practice items covered issues like previous recipient of pain management training, number of such trainings attended and by whom, location and perceived cause of pain encountered in practice, painful conditions ever referred and what influenced the referral and interest in future training whether previously trained or not. Of the 24 items on knowledge, 11 items were assessed on a 3-point Likert scale (Yes, I agree; I am not sure and No, I disagree). The responses to the 11 items were taken as an indicator of knowledge and were categorized into correct, incorrect or unsure answers.23 The remaining 13 items with multiple-choice responses were categorized into a 3-answer format: correct, incorrect and unsure with responses closely related to the correct answer categorized as incorrect and those unrelated to the correct response as unsure. For instance, item 13: adjuvant is an unrelated response while non-opioids and strong opioids are closely related responses to the correct response (weak opioids). The responses to the 24 items were taken as an indicator of knowledge and were categorized into correct, incorrect or unsure answers.23 For each participant, the raw number of correct, incorrect and unsure answers were scored (Table 1). Correct answers were based on the criteria of pain therapy from Guidelines for the management of pain in Nigeria,26 Pediatric Nurses’ Knowledge and Attitude Survey (PNKAS-Shriners Revision),48 and previous studies.23,44–46 Items related to knowledge and attitude were analyzed as a single concept in accordance with previous studies.23,49

Table 1

Community Pharmacists’ Knowledge and Attitude to Pediatric Pain in Nigeria (N=375)

Items	Correct Options	% Correct Answers	% Incorrect Answers	% Unsure/Missing Answers	Item Difficulty Indices	Item Discrimination Indices
1. Pain is considered as one of the vital signs in paediatric patients	Y	72.1	24.0	3.9	0.68	0.46
2. Visual analogue scale is a pain intensity rating scale for children with pain	Y	45.1	30.7	24.2	0.5	0.16
3. Pain intensity of a child with pain should be rated by the pharmacist	N	45.8	50.5	3.7	0.46	0.03
4. If the child with pain can be distracted that means he/she does not have a high intensity of pain	N	35.0	53.0	12.0	0.41	0.06
5. Repeated painful procedures on children increase their pain tolerance	N	36.0	47.7	16.3	0.41	0.25
6. Children may sleep in spite of being in severe pain	Y	24.8	67.5	7.7	0.23	0.19
7. Infants feel less pain than adults in similar situation	N	66.3	25.6	8.1	0.67	0.08
8. Infants forget painful episodes more quickly than adults	N	22.8	66.5	10.7	0.25	0.01
9. Children with pain should be encouraged to endure as much pain as possible before resorting to pain relief measures	N	73.9	21.0	5.1	0.72	0.01
10. Frequent request of analgesic by the child with pain means he/she is already addicted	N	43.7	46.6	9.9	0.42	0.30
11. A 10-year-old patient with a pain score of 5 can be effectively treated with codeine	N	43.7	25.5	30.8	0.23	0.01
12. Choice of analgesic recommended should depend on: a. Pain intensity. b. Patient’s age. c. Pain duration. d. Pain origin	A	52.4	42.6	5.0	0.52	0.41
13. WHO analgesic ladder for children does not include: a. Weak opioids. b. Adjuvants. c. Non-opioids. d. Strong opioids.	A	13.5	84.0	2.5	0.17	0.08
14. All are types of OTC analgesic except: a. Paracetamol. b. Ibuprofen. c. Diclofenac. d. Tramadol	D	87.6	11.4	1.0	0.86	0.21
15. All are examples of analgesic adjuvants except: a. Carbamazepine. b. Celecoxib. c. Amitriptyline. d. Dexamethasone	B	40.0	54.8	5.2	0.16	0.12
16. All are mechanisms of action of paracetamol-induced analgesia except: a. COX inhibition at its peroxidase site. b. Serotonin receptor activation. c. NAPQI metabolite activity. d. AM404 metabolite activity.	C	9.9	84.9	5.2	0.06	0.08
17. The recommended analgesic dose of paracetamol in children ≥ 3 months: a. 5mg/kg/wt. b. 7.5mg/kg/wt. c. 10mg/kg/wt. d. 15mg/kg/wt.	D	9.5	88.6	1.9	0.13	0.23
18. The recommended analgesic dose of paracetamol in children ≥ 3 months: a. 5mg/kg/wt. b. 7.5mg/kg/wt. c. 10mg/kg/wt. d. 15mg/kg/wt	D	9.7	87.4	2.9	0.05	0.06
19. The recommended analgesic dose of ibuprofen in children: a. 2.5mg/kg/wt. b. 5mg/kg/wt. c. 7.5mg/kg/wt. d. 10mg/kg/wt.	D	17.4	78.3	4.3	0.20	0.21
20. All are preferred for a 13-year old with musculoskeletal pain except: a. Paracetamol. b. Ibuprofen. c. Aspirin. d. Diclofenac.	C	52.4	37.8	3.3	0.65	0.42
21. OTC paracetamol use is contraindicated in children: a. < 3 months old. b. With malnutrition. c. With chicken pox. d. None of the above.	D	60.5	66.5	1.7	0.66	0.61
22. OTC paracetamol use is contraindicated in children: a. Dehydration. b. Asthma. c. Pneumonia. d. None of the above	D	54.7	42.2	3.1	0.57	0.61
23. OTC ibuprofen use is contraindicated in children: a. < 3 months old. b. With chicken pox. c. Dehydration. d. Pneumonia. e. All of the above	D	23.0	74.5	2.5	0.29	0.29
24. All are non-pharmacological approaches to paediatric pain management except: a. Physical therapy. b. Hypnosis. c. Music therapy. d. None of the above	D	54.7	42.2	3.1	0.57	0.61
TOTAL		40.25	52.45	7.30

Participants

The study participants (517) were those who met the study eligibility criteria such as attending the ACPN national conference, being registered members of ACPN and have attended to children with pain in the last 6 months. However, only the data of 357 (70% males, 30% females) respondents who completed the 24 questions/items assessing the knowledge and attitude of pediatric pain were analyzed.

Procedure for Data Collection

CPSPP was administered to the 623 eligible CPs who were invited to participate in the study and only 517 completed the questionnaire. However, only the data of 375 CPs (out of 517 CPs) who completely filled the 24 items on knowledge and attitude were analyzed. The introductory part of the questionnaire provided participants with information on study aim and objectives, that participation was voluntary and they were all assured of the confidential handling of the information provided. Participants’ consent was sought with the following statement and a Yes- and No- box: “Please tick (√) the Yes-box if you agree to take part in this study”.

Data Analysis

Data were analyzed using IBM SPSS statistics software, version 25.0 (IBM Corporation, Armonk, NY, USA: released 2017). The knowledge and attitude data were tested for normality with the Shapiro–Wilk test (p > 0.05). The demographic profile and data related to pediatric pain management were described with frequencies and proportions. Correct, incorrect and unsure answers were calculated for each knowledge item. Cronbach α, intra-class correlation coefficient (ICC), item difficulty and discrimination indices were used to evaluate the psychometric properties of CPSPP. A t-test for independent samples was used to examine the differences in knowledge scores between male and female participants, those with additional academic qualifications - including clinically related vs non-clinically related degrees and those who ever referred encountered painful episodes vs those who did not. Further, one-way between-group analysis of variance (ANOVA) was used to determine whether knowledge score levels differed by age groups, type of practice before entry into community pharmacy practice, years of practice in community pharmacy, geographical location and ownership structure of the practice. Following the univariate analyses, associations and relationships with p values ≤0.05 were considered significant and their effect sizes were determined using Eta squared-0.01 (small effect); 0.06 (moderate effect); 0.14 (large effect).50

Results

Demographic Profiles and Referral Practices of the Participants

The response and completion rates were 83.0% (517/623) and 72.5% (375/517), respectively. Most of the participants are aged 40–49 years (29%; 110/375), self-employed (61%; 227/375), commenced practicing in the hospital (64%; 163/255) before venturing into community pharmacy practice within the last 10 years (53%; 199/375) and practicing in the Northwestern part of Nigeria {32%; 121/375} (Table 2). Referral of painful episodes encountered was done by 68% (255/375) of participants and mostly (47%; 96/203) for patients/clients to access better care. The participant-reported perceived causes of pediatric pain encountered were mostly due to diseases (51%; 168/327) such as arthritis (15%; 25/168), infections (25%; 42/168), and sickle cell (23%; 39/168) (Table 2). Majority (71%; n=266) of the participants had Bachelor of Pharmacy degree as their highest academic qualification and those with two or more second degrees had the highest percentage of correct answers (45.2%) and lowest percentages of incorrect (39.3%) and unsure answers (15.6%) regarding the knowledge component of CPSPP (Figure 1). However, these differences in knowledge of pediatric pain management were not statistically significant (F(2372)=0.965, p=0.382). The part of the body most frequently associated with pediatric pain was neck/shoulder (27.6%; 56/203), followed by generalized/non-localized (20.2%; 41/203) and limb (19.7%; 40/203). Participating CPs from the Northeastern part of Nigeria had the highest proportion of correct answers (45%) and were closely followed by those practicing in both Northwestern and Southeastern Nigeria (43%).

Table 2

Sociodemographic Characteristics of the Participants Who Responded to Community Pharmacists Survey on Pediatric Pain Management in Nigeria (N=375)

Characteristics	Frequency n (%)
Gender
Male	262 (70.0)
Female	113 (30.0)
Age group (years)
20–39	52 (14)
30–39	99 (26)
40–49	110 (29)
50–59	65 (17)
≥ 60	49 (13)
Years of qualification
1–10	145 (39)
11–20	10 (27)
21–30	77 (21)
31–40	42 (11)
≥ 41	11 (3)
Years of practice
1–10	199 (53)
11–20	84 (22)
21–30	60 (16)
31–40	32 (9)
Previous area of practice
Yes	255 (68)
No	120 (32)
Areas previously practiced
Hospital	171 (67.1%)
Industrial	63 (25)
Hosp. + Ind.	21 (8)
Ownership structure
Self-owned	227 (61)
Co-owned	33 (9)
Employed	115 (31)
Geopolitical zone of practice
Northcentral	84 (22)
Northeast	24 (6)
Northwest	121 (32)
Southeast	15 (4)
Southsouth	59 (16)
Southwest	72 (19)
Ever trained on pain management
Yes	182 (49)
No	170 (45)
Cannot remember	23 (6)
Frequency of training on pediatric pain
Once	143 (79)
Twice	27 (15)
Thrice	12 (7)
Ever referred on pediatric pain
Yes	255 (68)
No	120 (32)
Reasons for referral
Pain intensity	45 (22)
Urgent care	16 (8)
Better care	96 (47)
Not responding to OTC analgesics	29 (14)
Pain etiology determination	17 (8)
Perceived cause of pain
aDisease-related	168 (51)
bSocial event-related	94 (29)
Menstruation	13 (4)
Unknown	52 (16)

Notes: aDisease-related: Arthritis-25, Cancer-7, Ulcer-10, Neuropathy-19, Infections-42 (Malaria-12, Bacterial infections-25, Dental abscess-3, Toothache-2), Sickle cell disease-39, Burns-7, Asthma-3, Appendicitis-3, Circumcision-1, Surgery-3, Diabetes (Diabetic foot)-3, Hernia-6; bSocial event-related: Home (Falls (8), Fights (20), Domestic accidents such as knife cuts-2), Road traffic accidents-49, Sports-15.

Abbreviations: Hosp, Hospital; Ind, Industrial; Pharma, Pharmacy.

Figure 1

Percentage of correct, incorrect and unsure answers by highest academic qualifications of the 375 participating community pharmacist.

Psychometric Properties of the Questionnaire

The knowledge and attitude items of the CPSPP demonstrated good reliability (α=0.681; ICC=0.693). The Item Difficulty Indices ranged from 0.05 (item 18) to 0.86 (item 14). Almost all the items had their Difficulty Indices within the optimal level (0.2–0.8) except for items 13, 14–18 (Table 1).51 The Item Discrimination Indices also ranged from 0.01 (items 8, 9, 11) to 0.61 (items 21, 22).

Knowledge of and Attitude to Pediatric Pain Management

The mean correct answers were significantly higher for male CPs relative to female CPs (10.06 ± 5.19 {41.9%} vs 9.90 ± 6.13 {41.3%}; t= 4.98, p < 0.05, Eta2=0.06), while the mean of incorrect answers was significantly lower for male participants (9.78 ± 4.20 {40.8%}) relative to females (9.82 ± 4.98 {40.9%}) (t= - 5.90, p < 0.05, Eta2=0.09) (Table 3). Table 3 also shows the performance of CPs in relation to their additional academic qualifications, the type of second degrees earned, having practiced in other areas of the profession before venturing into community pharmacy practice and knowing the cause of the painful episodes encountered. However, in terms of practice of pediatric pain management, referral practice was not significantly associated with knowledge of pediatric pain management. Those who reported not ever referring patients had a significantly higher mean of correct answers than their counterparts who reported referral of some painful episodes to orthodox health facilities (Ever referred: 9.83 ± 5.43 (41.0%); Not ever referred: 10.22 ± 5.54 {42.6%}; t= −1.17, p=0.36) and consequently had a lower mean of incorrect answers than their counterparts who reported ever referral of some pediatric painful episodes to orthodox health facilities (Ever referred: 9.92 ± 4.75 {41.3%}; Not ever referred: 9.64 ± 4.15 {40.2%}; t= 1.88, p=0.11). Those who do not report ever referring a pediatric patient for pain-related conditions had a lower mean of unsure answers than their counterparts who do report ever referring such patients (Ever referred: 4.24 ± 3.76 {17.7%}; Not ever referred: 4.12 ± 3.79 {17.2%}; t= 0.82, p=0.42).

Table 3

Community Pharmacists’ Knowledge and Attitude to Pediatric Pain in Nigeria According to Their Demographic and Clinical Profiles (N=375)

Characteristics	Correct Answers M±SD (%)	Incorrect Answers M±SD (%)	Unsure Answers M±SD (%)	t-test Statistics tc; ti; tu	F- test /Statistics	Eta2t; Eta2f; Ec; Ei; Eu
Gender
Male	10.06±5.19(41.9)	9.78±4.20(40.8)	4.16±3.36(17.3)	4.98p; −5.90p;		0.06; 0.09;
Female	9.90±6.13(41.3)	9.82±4.98(40.9)	4.28±4.15(17.8)	−2.91p		0.02
Add. Qualifications
Yes	10.02±5.15(41.7)	9.92±4.03(41.3)	4.07±3.80(16.9)	4.33p; 5.16p;		0.05; 0.07
No	9.97±5.61(41.6)	9.74±4.57(40.6)	4.26±4.57(17.8)	−2.39p		0.02
Second degree types
Clinically-related	10.02±5.32(41.8)	9.98±4.33(41.6)	4.00±3.88(16.7)	6.34p; 7.72p;		0.27; 0.35
Non-clinically related	9.44±5.67(39.4)	9.72±4.07(40.6)	4.80±4.88(20.0)	−3.04q		0.08
Practiced elsewhere before comm. pharm.
Yes	10.16±5.35(41.4)	9.83±4.09(41.6)	4.01±3.58(17.0)	4.26q; 5.38p;		0.05; 0.07
No	9.70±5.68(40.4)	9.73±4.88(40.5)	2.15±4.31(19.1)	2.21p		0.01
Cause of pain
Known	10.02±5.53(41.7)	9.82±4.90(41.7)	4.17±3.87(17.4)	7.16p; 7.90p;		0.20; 0.24;
Not known	9.77±5.40(40.7)	9.65±4.84(40.2)	4.58±4.00(19.1)	4.14q		0.08
Age group (years)
20–29	9.75±5.79(40.6)	9.75±4.78(40.6)	4.5±3.26(18.8)		2.858p	0.03
30–39	10.35±5.70(43.1)	10.08±4.79(42.0)	3.57±1.70(14.9)
a40–49	10.78±5.80(44.9)	9.16±5.11(38.2)	4.06±4.36(16.9)
b50–59	9.15±6.62(38.1)	10.14±4.39(42.3)	4.71±3.91(19.6)
≥60	8.10±6.07(33.8)	10.24±5.05(42.6)	5.66±2.79(23.6)
Ownership
Self-owned	9.76±5.39(40.7)	9.84±4.25(41.0)	4.40±1.90(18.3)		3.643p	0.02
Joint ownership	9.24±5.72(38.5)	10.00±4.70(41.7)	4.76±2.24(19.8)
In employment	10.74±5.83(44.8)	9.65±4.87(40.2)	3.61±1.82(15.0)
Geopolitical zones
North-central	9.80±5.26(40.8)	10.17±3.69(42.4)	4.03±1.46(16.8)		4.497p	0.06
North-east	10.91±5.51(45.5)	8.83±4.77(36.8)	4.26±2.30(17.8)
aNorth-west	10.40±5.91(43.3)	9.65±4.95(40.2)	3.95±2.03(16.5)
cSouth-east	10.27±4.63(42.8)	8.67±2.53(36.2)	5.06±1.48(21.1)
South-south	10.11±5.13(42.2)	9.53±5.30(39.7)	4.36±2.42(18.2)
bSouth-west	9.17±6.32(38.2)	10.38±5.08(43.3)	4.45±2.18(18.5)
Years of practice
a1–10	10.36±5.40(43.2)	9.87±4.33(41.1)	3.77±1.65(15.7)		3.985p	0.03
c11–20	10.29±6.17(42.9)	9.54±5.31(39.8)	4.17±2.32(17.3)
d21–30	9.40±5.26(39.2)	9.58±4.44(39.9)	5.02±2.33(20.9)
b31–40	8.28±6.70(34.5)	10.38±5.08(43.3)	5.34±2.67(22.2)
Perceived cause
bDisease-related	9.21±5.50(38.4)	10.23±5.30(42.6)	4.56±2.36(19.0)		4.168p	0.06
aSocial-related	11.02±6.08(45.9)	9.41±5.02(39.2)	3.57±1.90(14.9)
Menstruation	8.70±2.98(36.3)	10.2±1.09(42.5)	5.10±0.55(21.2)
Not reported	9.70±5.72(40.4)	9.70±5.05(40.4)	4.60±2.39(19.2)
Ever trained
Yes	10.38±5.31(43.3)	9.57±4.04(39.9)	4.05±1.71(16.9)		3.587p	0.02
No	9.71±5.73(40.5)	10.02±4.90(41.8)	4.27±2.09(17.8)
Cannot remember	9.35±5.58(39.0)	9.87±4.94(41.1)	4.78±2.39(19.9)

Notes: a, b, c, d-categories of each group where the statistical significance in mean difference lie; pP<0.05; qP≤0.005.

Abbreviations: M±SD, Mean±Standard deviation; %, Percentage of those with the respective mean knowledge score; F, statistics-For One-Way analysis of variance (ANOVA); tc, t-test statistic for correct answers; ti, t-test statistic for incorrect answers; tu-, t-test statistic for unsure answers; F, test: statistic for one-way analysis of variance; Eta2t, for t-test; Eta2f, for one-way analysis of variance; Ec, Eta2 for correct answers; Ei, Eta2 for incorrect answers; Eu, Eta2 for unsure answers; Add., Additional; comm., community; pharm., pharmacy.

CPs’ responses were also evaluated in relation to their demographic profiles and some aspects of pediatric pain management. Results of ANOVA showed that those in the 40–49 age group category had significantly higher mean correct answers relative to others (10.78 ± 5.80, F(4370)=2.858, p=0.025, Eta2=0.03) (Table 3). Other components of the demographic profiles of the participants that produced significant differences in knowledge of pediatric pain management are participants’ years of practicing community pharmacy, ownership structure of the premises, regional location of the premises, previous exposure to pain management training and perceived cause of painful episodes encountered (Table 3). However, there was no significant difference in knowledge of pediatric pain management based on years of qualification F(2372)=0.965; p=0.382), despite those who qualified to practice pharmacy between 11 and 20 years ago (M=10.56 ± 5.70) scoring the highest mean of correct answers, followed by those who qualified within a decade ago (M=10.22 ± 5.59). The type of career chosen before venturing into community pharmacy had no significant influence on CPs’ knowledge of pediatric pain management. CPs who previously practiced in the hospital (M=10.50 ± 5.40) had the highest mean correct answers; followed by those who have academic pharmacy experience, hospital and administrative pharmacy experiences (M=10.13 ± 2.60) (F(3251)=4.761, p=0.123). The number of previous pain management trainings attended by participants had no significant effect on their knowledge (F(2179)=0.565, p=0.569).

Discussion

This survey is probably the first to provide an insight into the knowledge of pediatric pain management among community pharmacists in a developing setting like Nigeria. Findings from the survey showed that CPs are a major primary healthcare provider that frequently attend to pediatric patients with various painful conditions and thus may contribute significantly to the effective management of pediatric pain in Nigeria. The outcome of the survey also revealed that participants answered two of every five questions on pain knowledge correctly and this significantly vary with age group, years of practicing community pharmacy, ownership structure of premises, geographical location of practice and previous exposure to pain management training.

Notwithstanding the general dearth of published studies on pediatric pain management among CPs, our finding is consistent that of Patel et al who reported inadequate knowledge of chronic pain among CPs.39 In addition, our finding is also consistent with the inadequate knowledge of the management of cancer-related pain reported among hospital pharmacists.16,19,36 Therefore, there is a clear need for regular audit of CPs’ knowledge of the management of pediatric pain to identify relevant gaps, develop and implement appropriate interventions to improve the effectiveness of service delivery.

Our study finding showing that neck/shoulder pain was reported by CPs as the most commonly encountered among pediatric patients in practice is being reported for the first time. However, a recent Australian survey investigating CPs’ views and practices of pain and fever management in the general population reported back pain to be the most commonly encountered.25 This contrast is apparently due to the difference in study population. This is because published reports of the location of pain experienced among children generally seemed to vary based on geographical location and data collection methods.5

Possession of clinically related additional qualification, including Pharm D and fellowship of West African Postgraduate College of Pharmacists, had the strongest relationship with higher knowledge of pediatric pain management among participants in the current survey. A similar finding has also been reported among hospital pharmacists delivering oncology services.37 Similarly, having practiced in other areas such as the hospital before commencing community pharmacy practice was associated with higher knowledge of pediatric pain management among the CPs sampled. This might probably be due to the impact of the pain management training provided by PFHI that trained over 11,000 HCPs including at least one-tenth of the respondents in the current survey. Furthermore, previous training on pain management appeared to have had a positive impact on the CPs’ knowledge of pediatric pain management in the current study. This finding is not surprising, as the role of educational intervention in improving pediatric pain knowledge of HCPs is well documented in published literature.52–55

Overall, CPs residing in Northeastern Nigeria had the highest mean correct answers. This interesting finding require further exploration as it is not really clear what factors may have accounted for the observed trend. This is because the pervasive insecurity in the Northeastern region of Nigeria has led to limited availability of HCPs and disruption of health systems which could interfere with knowledge acquisition, professional practice and optimal patient outcome.56,57 However, regional geographic differences in pain management knowledge have been reported generally among HCPs.36 In addition, physician opioid prescribing practices and pharmacists’ concerns with stocking narcotics have also been reported to vary by regional geographic location.58,59 Another interesting finding in the current survey that require further exploration is that CPs who are employees had significantly higher knowledge scores relative to those who own their practice. It is probable that community pharmacist employees may have had additional training exposure and practice experience related to the management of pediatric pain and this may have been responsible for the higher mean knowledge scores observed among them.

It is noteworthy that, despite the CPs’ correct answer to the item on codeine use (item 11) attracting more than the average score and higher than that reported by He et al;60 seeking more information on codeine and opioids especially best practices regarding its handling from reliable sources is recommended.2,61–65 Codeine is a weak opioid that is no longer recommended for moderate pain in the pediatric population but rather low-dose morphine,26,66 and in fact its use in those less than 12 years old has been contraindicated.65

Like all studies, this survey is not without limitations and hence the findings reported should be interpreted in the light of limitations such as the use of non-probability sampling method. However, the large size of the purposive sample of study participants was taken from the largest annual gathering of CPs from all the geopolitical zones in Nigeria, and this may have mitigated potential risk of wide variability and generalizability. Furthermore, recall and social desirability bias might have been introduced into the survey as most of the responses were from self-report. In addition, it is quite possible that majority of the respondents were those with interest or experience in pain management and this could have affected the findings reported. However, the development and use of a questionnaire with robust psychometric properties for data collection may have mitigated this and probably suggest that the findings reported are valid and robust. In addition, social desirability bias appeared not to have affected the findings as revealed by the low mean scores reported by community pharmacists for some of the items used for the assessment of knowledge of pediatric pain management. Furthermore, effect sizes were determined on significant findings to quantify the strength of relationship and association.

Conclusion

Community pharmacists’ knowledge of and attitude to pediatric pain management in Nigeria appeared sub-optimal, and requires regular targeted educational intervention to fill the identified gaps, improve service delivery and patient outcomes. This could be achieved successfully through concerted efforts by all relevant stakeholders including the FMOH, Pharmacists Council of Nigeria, Pharmaceutical Society of Nigeria, Nigeria Association of Pharmacists in Academia and ACPN. Overall, community pharmacists’ knowledge of pediatric pain management in Nigeria significantly vary by age group, years of practice, ownership structure, geographical location of practice and previous exposure to pain management training.